Zanidatamab zovodotin | m-entrepreneurship.com

Product Name :
Zanidatamab zovodotin

Search keywords :
Zanidatamab

drugId :
null

Target Vo:
Receptor protein-tyrosine kinase erbB-2

Target Vo Short Name :
HER2

Moa_Name:
Receptor protein-tyrosine kinase erbB-2 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Zymeworks Inc

Active Company_Name :
Beigene Ltd

Active Indication_Name:
Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Mst2 Antibody
xCT Antibody (YA006)
Phospho-STAT5 (Tyr694) Antibody (YA145): Phospho-Stat5 (Tyr694) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 91 kDa, targeting to Phospho-Stat5(Y694). It can be used for WB,IHC-P assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts